A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...

McDonald's is suing major meatpackers for allegedly colluding to inflate beef prices by limiting supplies since 2015. PepsiCo ...

On October 2, 2024, the U.S. Food and Drug Administration (FDA) determined the shortage of the tirzepatide injection, a glucagon-like peptide ...

Even though there is no official Ozempic Diet, there are certain foods you can avoid to minimize your chances of negative ...

FDA faces legal action after removing Tirzepatide from the shortage list without following required procedures, sparking ...

With an estimated 2 million people in the United States taking copycat vers | A compounding industry group has sued the FDA, ...

While artificial intelligence (AI) has been one of the hottest investing trends, GLP-1 weight loss drugs are a close second.

When a drug is on FDA’s drug shortage list, outsourcing facilities by law may help address the drug shortage by producing an “essential copy” version of the shortage drug using bulk drug substances.

Now that Mounjaro has been authorised for use on the NHS, it will be key that access to specialist weight loss services is ...

A group representing makers of compounded drugs sued FDA over its decision to call an end to the shortage of Lilly's (LLY) ...

All doses of the diabetes and weight management injectable tirzepatide (Mounjaro, Zepbound) were taken off the FDA's shortage ...

Eli Lilly shares have soared thanks to excitement about the company's position in the weight loss drug market.